Drugs / T2 [arm: experimental] — 1.5mg/kg/day, PO (per oral),three times a day: until progression or unacceptable toxicity develops
T2 [arm: experimental] — 1.5mg/kg/day, PO (per oral),three times a day: until progression or unacceptable toxicity develops
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01015391 | Nov 2009 → Jun 2013 | Crohn disease | Jinling Hospital, China | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | T2 [arm: experimental] — 1.5mg/kg/day, PO (per oral),three times a day: until progression or unacceptable toxicity develops | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01015391 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “T2 is a chloroform/methanol extract Tripterygium wilfordii Hook F (TWHF), the traditional Chinese medicine” NCT01015391 ↗ |
| Route | Oral | “PO (per oral)” NCT01015391 ↗ |